Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01256541 · ClinicalTrials.gov registry record · Phase 1
Kristalose as Bowel Evacuant Prior to Colonoscopy
A Phase 1 study, sponsored by Benaroya Research Institute.
- Completed
- Registry status
- Phase 1
- Development phase
- 20
- Enrollment target
NCT01256541 is a Phase 1 study that has completed, run by Benaroya Research Institute. The registered enrollment target is 20 participants.
The verdict
NCT01256541, a Phase 1 study, has completed, sponsored by Benaroya Research Institute.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 20 participants
- Enrollment target
Study Summary
To determine whether Kristalose causes a significant increase in hydrogen and/or methane gas levels in patients requiring bowel evacuation, and also to determine the safety, efficacy, and patient preference of Kristalose as a bowel evacuant
Interventions
- DRUG Kristalose
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2010-12 |
| Est. Completion | 2011-09 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01256541
The ClinicalTrials.gov registry entry for NCT01256541 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Benaroya Research Institute, which has 28 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Kristalose is the first listed.
NCT01256541 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01256541 about?
NCT01256541 is a clinical study titled "Kristalose as Bowel Evacuant Prior to Colonoscopy". To determine whether Kristalose causes a significant increase in hydrogen and/or methane gas levels in patients requiring bowel evacuation, and also to determine the safety, efficacy, and patient preference of Kristalose as a bowel evacuant
What is the current status of trial NCT01256541?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2010-12. Estimated completion is 2011-09.
What interventions are being tested in trial NCT01256541?
The interventions under investigation include: Kristalose (DRUG).
Who is sponsoring clinical trial NCT01256541?
This trial is sponsored by Benaroya Research Institute, which has 28 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.